Evidence map›Paper›PMID 41524034›Full record

ArticleJournal of arrhythmia2026

Novel Echocardiographic Index for Risk Stratification of Ventricular Arrhythmias and Mortality Based on Right Ventricular Function.

Toshinori Chiba, Takatsugu Kajiyama, Yusuke Kondo, Hiroyuki Takaoka, Noriko Suzuki-Eguchi, Masahiro Nakano, Miyo Nakano, Satoko Ryuzaki, Yukiko Takanashi, Yuya Komai and 2 more

Abstract read
In one paragraph

Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Right ventricular dysfunction: an overlooked predictor of sudden cardiac death and arrhythmic events-a meta-analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Toshinori ChibaDepartment of Advanced Cardiorhythm Therapeutics Chiba University Graduate School of Medicine Chiba Japan.ORCID https://orcid.org/0009-0002-8386-7592
Takatsugu KajiyamaDepartment of Advanced Arrhythmia Bioengineering Chiba University Graduate School of Medicine Chiba Japan.ORCID https://orcid.org/0000-0003-3990-7120
Yusuke KondoDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan.ORCID https://orcid.org/0000-0003-4985-6929
Hiroyuki TakaokaDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan.
Noriko Suzuki-EguchiDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan.
Masahiro NakanoDepartment of Advanced Cardiorhythm Therapeutics Chiba University Graduate School of Medicine Chiba Japan.
Miyo NakanoDepartment of Advanced Cardiorhythm Therapeutics Chiba University Graduate School of Medicine Chiba Japan.
Satoko RyuzakiDepartment of Advanced Arrhythmia Bioengineering Chiba University Graduate School of Medicine Chiba Japan.
Yukiko TakanashiDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan.
Yuya KomaiDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan.
Yusei NishikawaDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan.
Yoshio KobayashiDepartment of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Right ventricular (RV) dysfunction is independently predictive of sudden cardiac death. This study aimed to compare the performance of different risk stratification methods for death and appropriate implantable cardioverter-defibrillator (ICD) therapy using echocardiography and cardiac magnetic resonance imaging (CMR) to quantify RV function. Methods: Consecutive patients undergoing ICD implantations who had completed both preprocedural echocardiography and CMR were retrospectively enrolled. Patients with channelopathies or arrhythmogenic right ventricular disease were excluded. The RV fractional area change (RVFAC) and estimated pulmonary artery pressure (EPAP) were calculated from echocardiography. The contraction pressure index (CPI) was defined as the quotient of the RVFAC divided by the EPAP. Both metrics were used to predict the composite endpoint of death and an appropriate ICD therapy. RV dysfunction was defined by either RVFAC < 35% or RV ejection fraction (RVEF) < 45%. Results: In total, 88 patients (60.4 ± 14.7 years, 61 males) including 15 with ischemic cardiomyopathy were retrospectively enrolled. Forty-two patients received ICDs as secondary prevention. The mean RVFAC, CPI, and RVEF were 35.9% ± 9.22%, 1.4% ± 0.7%/mmHg, and 39.5% ± 14.4%, respectively. Regarding the composite endpoint, the best cut-off value of the CPI was 1.59 (specificity 0.45, sensitivity 0.96, ROC-AUC 0.68). The hazard ratio of a low RVFAC was 3.28 (95% CI: 1.39-7.77, Conclusion: Both CMR-derived RVEF and the echocardiographic CPI predicted appropriate ICD therapy and death. The CPI may provide superior risk stratification.

Indexed as

heart failureICD therapyright ventricular dysfunctionsudden cardiac death

Identifiers

PMID41524034
PMCPMC12783901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.